The reductions in CR-1 protein levels were associated with a global reduction in tumorigenicity, such as decreased growth potential, reduced number of colonies in soft agar assays or smaller tumor mass induction in mouse xenografts, and a regained sensitivity towards some chemotherapeutics such as 5-FU [100,101,102,103]. Here, CR1 is linked to neoplasm.